Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide

European Journal of Clinical Pharmacology

Volumn 49, Issue 5, 1996, Pages 393-396

  Lysaa, R A ^a   Giverhaug, T ^a   Libaek Wold H ^a   Aarbakke, J ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Bendroflumethiazide; Diuretics; Furosemide; Thiopurine methyltransferase; Trichlormethiazide

Indexed keywords

BENDROFLUMETHIAZIDE; FUROSEMIDE; MERCAPTOPURINE; S ADENOSYLMETHIONINE; THIOPURINE METHYLTRANSFERASE; TRICHLORMETHIAZIDE;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0030027378     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00203784     Document Type: Article

References (21)

1. Aarbakke J (1995) Biology and pharmacology of thiopurines. Ped Hemat Oncol. 12:511-519
2. Paterson ARP, Tidd DM (1975) 6-Thiopurines. In Antineoplastic and immunosuppressive agents II, Sartorelli AC, Johns DG, (eds.) Springer, New York 384-403
3. Remy CN (1963) Metabolism of thiopyrimidines and thiopurines: S-methylation with S-5′-adenosylmethionine transmethylase and catabolism in mammalian tissue. J Biol Chem 238: 1078-1084
4. Woodson LC, Weinshilboum RM (1983) Human kidney thiopurine methyltransferase: Purification and biochemical properties. Biochem Pharmacol 32: 819-826
5. Woodson LC, Dunnette JH, Weinshilboum RM (1982) Pharmacogenetics of human thiopurine methyltransferase: Kidney-erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 222:174-181
6. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM (1992) Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isoenzymes. Pharmacogenetics 2:148-159
7. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM (1990). Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336:225-229
8. Chocair PR, Duley JA, Simmonds HA, Cameron JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53:1051-1056
9. Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenetic inheritance of erythrocyte methyltransferase activity. Am J Human Genet 32:651-662
10. Klemetsdal B, Tollefsen E, Loennechen T, Johnsen K, Utsi E, Gisholt K, Wist E, Aarbakke J (1992) Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther 51:24-31
11. Klemetsdal B, Wist E, Aarbakke J (1993) Gender difference in red blood cell thiopurine methyltransferase activity. Scand J Clin Lab Invest 53:747-749
12. Klemetsdal B, Straume B, Lysaa R, Giverhaug T, Aarbakke J (1995) Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity. Eur J Clin Pharmacol 48:495-499
13. Woodson LC, Ames MM, Selassie CD, Hansch C, Weinshilboum RM (1983) Thiopurine methyltransferase: aromatic thiol substrates and inhibition by benzoic acid derivatives. Mol Pharmacol 24:471-478
14. Deininger M, Szumlanski CL, Otterness DM, Van Loon J, Ferber W, Weinshilboum RM (1994) Purine substrates for human thiopurine methyltransferase. Biochem Pharmacol 48:2135-2138
15. Szumlanski CL, Weinshilboum RM (1995) Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 39:456-459
16. Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44:147-152
17. Weinshilboum RM, Raymond FA, Pazmino PA (1978) Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties. Clin Chim Acta 85:323-333
18. Honchel R, Aksoy I, Szumlanski C, Wood TC, Otterness DM, Wieben ED, Weinshilboum RM (1993) Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol Pharmacol 43:878-887
19. Segel IH (1975) Enzyme kinetics. John Wiley, New York
20. Van Meyel JJM, Gerlag PGG, Smits P, Russel FGM, Tan Y, Van Ginneken CAM, Gribnau FWJ (1992) Absorption of high dose furosemide (frusemide) in congestive heart failure. Clin Pharmacokinet 22:308-318
21. Ponto LLB, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (part I). Clin Pharmacokinet 18:381-408